Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001666690-17-000001
Filing Date
2017-05-11
Accepted
2017-05-11 16:42:05
Documents
1
Effectiveness Date
2017-05-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5907
  Complete submission text file 0001666690-17-000001.txt   6974
Mailing Address 8601 SIX FORKS ROAD SUITE 400 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 400 RALEIGH NC 27615 919-275-1933
Innovate Biopharmaceuticals Inc. (Filer) CIK: 0001666690 (see all company filings)

EIN.: 462638163 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-286577 | Film No.: 17834954